X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare IPCA Labs with FDC LTD. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs FDC LTD. - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    IPCA LABS FDC LTD. IPCA LABS/
FDC LTD.
 
P/E (TTM) x 29.2 18.9 154.5% View Chart
P/BV x 3.7 3.8 98.7% View Chart
Dividend Yield % 0.1 1.3 10.0%  

Financials

 IPCA LABS   FDC LTD.
EQUITY SHARE DATA
    IPCA LABS
Mar-18
FDC LTD.
Mar-14
IPCA LABS/
FDC LTD.
5-Yr Chart
Click to enlarge
High Rs695144 484.6%   
Low Rs40079 506.3%   
Sales per share (Unadj.) Rs260.247.6 547.0%  
Earnings per share (Unadj.) Rs19.07.6 249.3%  
Cash flow per share (Unadj.) Rs33.19.0 366.9%  
Dividends per share (Unadj.) Rs1.002.25 44.4%  
Dividend yield (eoy) %0.22.0 9.0%  
Book value per share (Unadj.) Rs213.047.5 448.2%  
Shares outstanding (eoy) m126.20177.83 71.0%   
Bonus/Rights/Conversions -BB-  
Price / Sales ratio x2.12.3 90.0%   
Avg P/E ratio x28.914.6 197.5%  
P/CF ratio (eoy) x16.612.3 134.2%  
Price / Book Value ratio x2.62.3 109.8%  
Dividend payout %5.329.6 17.8%   
Avg Mkt Cap Rs m69,12019,784 349.4%   
No. of employees `00013.3NA-   
Total wages/salary Rs m7,3591,221 602.9%   
Avg. sales/employee Rs Th2,477.4NM-  
Avg. wages/employee Rs Th555.2NM-  
Avg. net profit/employee Rs Th180.6NM-  
INCOME DATA
Net Sales Rs m32,8368,459 388.2%  
Other income Rs m418394 106.2%   
Total revenues Rs m33,2548,852 375.7%   
Gross profit Rs m4,5052,070 217.6%  
Depreciation Rs m1,777249 713.5%   
Interest Rs m24031 774.6%   
Profit before tax Rs m2,9052,184 133.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-225 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m511606 84.4%   
Profit after tax Rs m2,3941,353 176.9%  
Gross profit margin %13.724.5 56.1%  
Effective tax rate %17.627.7 63.4%   
Net profit margin %7.316.0 45.6%  
BALANCE SHEET DATA
Current assets Rs m19,4554,355 446.7%   
Current liabilities Rs m10,0761,792 562.3%   
Net working cap to sales %28.630.3 94.3%  
Current ratio x1.92.4 79.4%  
Inventory Days Days9844 220.2%  
Debtors Days Days6725 271.4%  
Net fixed assets Rs m20,2603,025 669.7%   
Share capital Rs m252179 141.3%   
"Free" reserves Rs m26,6338,243 323.1%   
Net worth Rs m26,8868,453 318.1%   
Long term debt Rs m2,34011 21,870.1%   
Total assets Rs m41,17310,557 390.0%  
Interest coverage x13.171.4 18.3%   
Debt to equity ratio x0.10 6,876.1%  
Sales to assets ratio x0.80.8 99.5%   
Return on assets %6.413.1 48.8%  
Return on equity %8.916.0 55.6%  
Return on capital %10.823.5 45.8%  
Exports to sales %47.613.3 357.9%   
Imports to sales %14.93.3 444.8%   
Exports (fob) Rs m15,6421,126 1,389.5%   
Imports (cif) Rs m4,884283 1,726.9%   
Fx inflow Rs m15,6421,146 1,364.8%   
Fx outflow Rs m4,884355 1,374.5%   
Net fx Rs m10,759791 1,360.5%   
CASH FLOW
From Operations Rs m3,4111,485 229.7%  
From Investments Rs m-1,354-620 218.6%  
From Financial Activity Rs m-1,304-753 173.3%  
Net Cashflow Rs m753113 667.7%  

Share Holding

Indian Promoters % 45.9 68.9 66.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 11.4 4.7 242.6%  
FIIs % 25.3 7.5 337.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.4 19.0 91.6%  
Shareholders   36,892 23,730 155.5%  
Pledged promoter(s) holding % 2.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare IPCA LABS With:   ALEMBIC LTD  SUN PHARMA  PFIZER  GLENMARK PHARMA  SHASUN PHARMA  

Compare IPCA LABS With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

From Urjit Patel to Shaktikanta Das; What Lies Ahead?(Podcast)

The week gone by saw Sensex plunge from 700 points to rise by over 600 points. With a volatile and eventful week, it was a challenge keeping up with the news every day.

Related Views on News

FDC LTD. Announces Quarterly Results (2QFY19); Net Profit Down 33.6% (Quarterly Result Update)

Nov 23, 2018 | Updated on Nov 23, 2018

For the quarter ended September 2018, FDC LTD. has posted a net profit of Rs 431 m (down 33.6% YoY). Sales on the other hand came in at Rs 3 bn (down 12.0% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

IPCA LABS Announces Quarterly Results (2QFY19); Net Profit Up 24.1% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, IPCA LABS has posted a net profit of Rs 1 bn (up 24.1% YoY). Sales on the other hand came in at Rs 10 bn (up 15.4% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

It's Almost the Perfect Time to Buy This Safe Stock(The 5 Minute Wrapup)

Dec 6, 2018

My latest StockSelect recommendation ticks all the boxes of a great safe stock.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

Are Foreign Investors Heading Back to the Indian Stock Markets?(Chart Of The Day)

Dec 3, 2018

After months of heavy FII selling, November witnessed a return on foreign money into Indian equities...

DSP Mutual Fund's Sale of DHFL Bonds: Here's What You Need to Know(Outside View)

Dec 5, 2018

PersonalFN explains the probable reason as to why the capital market regulator has initiated DSP Mutual Fund's bond sale that caused DHFL stock to crash.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Dec 14, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS